Search
for
Sort by
Research 181–210 of 1000+
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Efficacy of fractional radiofrequency in the treatment of erythematous capillary rosacea: A split‐face study
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Current Aspects of Antiandrogen Therapy in Women
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- A four generation hidrotic ectodermal dysplasia family: an allelic variant of Clouston syndrome?
- Psychotropic Treatment of Psychodermatologic Disorders
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Safety and compatibility of a new nourishing baby shampoo and tip to toe wash with stearic acid
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- A New Approach with Combined Microneedle and Sublative Fractional Radiofrequency for Photoaging Management: A Clinical, Histometric, and Immunohistochemical Study
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Generating mouse models of degenerative diseases using Cre/lox-mediated in vivo mosaic cell ablation
- Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review
- Myo-Inositol for Cutaneous Manifestations of Polycystic Ovary Syndrome: An International Delphi Consensus Recommendation for Dermatology Practice
- Safety and Clinical Efficacy of KūlarisTM, an Herbal Supplement for Mild to Severe Acne Vulgaris – A 12-Week Randomized, Double Blind, Placebo-Controlled Study
- Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Pilot Evaluation of the Efficacy and Safety of Xtressé™ Gummy-Based Nutraceutical Supplement in Women with Hair Loss
- Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials
- Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Azelaic Acid in the Treatment of Acne in Adult Females: Case Reports
- Scalp Microinfusion: A Novel Drug Delivery Technique for Hair Loss Treatment
- Pruritus as a Symptom in Hyperthyroidism
- An Exosome Regenerative Complex Plus Microneedling Promotes Hair Growth in Subjects With Self-Perceived Thinning Hair.
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Characterization of the in vitro, ex vivo, and in vivo Efficacy of the Antimicrobial Peptide DPK-060 Used for Topical Treatment
- Rejuvenation of the male scalp using 1,927 nm non-ablative fractional thulium fiber laser
- Kerion Type of Tinea Capitis Treated with Double Pulse Dose Terbinafine
- Ichthyosis linearis circumflexa in a child. Response to narrowband UVB therapy.